Ads
related to: drug relapse rates
Search results
A second animal tranquilizer has infiltrated the state's street drugs, making deadly mark
Detroit Free Press· 16 minutes agoLike xylazine before it, the new drug, medetomidine, is a non-opioid animal tranquilizer that is not...
Immunotherapy drug may help 'cure' advanced colorectal cancer without surgery
MedicalNewsToday via AOL· 7 hours agoGiving the immunotherapy drug pembrolizumab before surgery instead of chemotherapy may help improve...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 5 hours agoAll key secondary endpoints (annualized flare rate; flare-free, treatment-free complete remission;...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 6 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with ...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 2 days agoRong Xu, professor of biomedical informatics and director of CWRU’s centre for artificial intelligence in drug discovery said it was an observational...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 13 hours agoOverall survival, complete response or better, very good partial response or better, the rate of...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 5 days agoAt a median follow-up of 21.8 months, the 12-month estimated PFS rates were 71% with BPd versus 51%...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoSunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations PR Newswire SHANGHAI, June 2, 2024 The global pivotal WU-KONG1B study investigating sunvozertinib achieved
Researchers identify a key metabolic gene as target for improved cancer immunotherapy
Medical Xpress· 10 hours agoInhibiting this gene through pharmacologic or genetic intervention led to better T-cell infiltration, increasing effectiveness of immunotherapy in a type of pancreatic cancer called PDAC. The ...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 7 days agoSquibb (BMS) has received approval from the US Food and Drug Administration for Breyanzi...
